Current Treatment of Alopecia Areata.

ABSTRACT: The number of alopecia areata (AA) clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases, including Jak1, Jak2, Jak3, and tyrosine-protein kinase has increased significantly since the last Research Summit. This fact means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies as well as evolving therapies as with Jak inhibitors.

SUBMITTER: Hordinsky MK 

PROVIDER: S-EPMC11549921 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature